Pharma 1 Flashcards

1
Q

What’s absorption
Distrubution
Metabolism
Elimination

A

Drug movement from its site to administration into the blood
Transfer of the drug in and out of tissue
Metabolism is biotransformation chemical changes mainly in liver
Elimination is losing of body from the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does it mean pharmaceutical form

A

Physical form of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 steps of a medicine til it appear in the blood

A

Disintegration of the tablet
Dissolution
Absorption
Appearing in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Physical factors that influencing absorption

A

Blood flow in the intestine is much higer and intense than in the stomach
Total surface area which is higher in the intestine microvili
Contact time
For example diarrhea or food in the stomach or parasympathetic or sympathetic input can effect absorption a lot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s presystemic metabolism and when does metabolism accrue?

A

Metabolism accrue before the drug reaches systemic circulation and its called presystemic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to count bioavailability? And what’s it

A

It’s the amount of a drug actually enter your bloodstream and available for your body to use it

Bioavailability (F)= ( AUCoral DEVIDE by AUCIV ) ×100=

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors effect bioavailability

A

Solubility of the pharmaceuticals form
Nature of the Pharmaceuticals
Destruction of the pharmaceuticals
First pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What’s biological and therapeutic equivalent
And what does biological equivalence compare

A

Two drugs are considered biologically equivalent if the release the same amount of medicine at the same rate into the blood
Comparable bioavailability
And comparable max plasma level

Therapeutical equivalent are two blood if they biologically equivalent and worked equally good to treat the same condition
Comparable safety and afficianty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is the generic medicine results and preclinical test and clinical trails are not required?

A

If the medicinal product has the same qualitative and quantitative substance and same pharmaceutical form as the original medicine form. And same bioequivavalnce
So in short
Quality and quantity and its form and bioequivalence should be the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What’s diestribution and is this process is reversible
Systemic affect occurs after distribution or before distribution?

A

It’s a distrubtion in which the drug reversible leaves the blood stream and enter extra cellular fluid or cell
And yes this process is reversible

Systemic effect occurs after distribution for local effect systemic distribution is not required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors effect the rate of distribution

A

Blood flow to the tissue
Capillary permeability
Drug structure
Protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Volume of Distribution (Vd)?

A

Answer: It’s a theoretical concept that tells us how widely a drug spreads in the body. It helps us understand if a drug stays in the blood or spreads into tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the formula for Volume of Distribution (Vd)?

A

Vd= D delad C
D = Dose of the drug.
C = Concentration of the drug in the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a small Vd mean?
What does a large Vd mean?

A

It means the drug mostly stays in the blood (e.g., heparin)
means the drug spreads widely into tissues (e.g., ethanol).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the compartments of distribution?

A

These are the “spaces” in the body where a drug can go, such as:

Plasma/Blood (about 4 L).
Extracellular Fluid (about 14 L).
Total Body Water (about 42 L).
Other sites (e.g., fetus).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which compartment do large molecules or protein-bound drugs (like heparin) stay in?
Which compartment do small, water-loving drugs (like aminoglycosides) spread into?
Which compartment do small, fat-loving drugs (like ethanol) spread into?

What does apparent volume of distribution (Vd) tell us?

A

They mostly stay in the plasma/blood (small Vd).
They spread into the extracellular fluid (medium Vd).
They spread into total body water, including inside cells (large Vd).

It tells us whether a drug stays in the blood (small Vd) or spreads into tissues (large Vd).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drugs Binding to plasma protein tell me what’s that

What is the significance of free (unbound) drug?
What are Class I drugs?

What are Class II drugs?
What happens when a Class II drug is given with a Class I drug?

A

When drugs enter the bloodstream, many of them bind to plasma proteins (like albumin). However, only the free (unbound) drug is active and can interact with tissues or receptors to produce an effect. The bound drug is inactive and acts as a “reservoir” in the blood.

Only the free drug is active and can produce a therapeutic effect. Bound drug is inactive.

Class 1 Drugs with a low dose, high binding to plasma proteins, and a high bound fraction (e.g., warfarin)

Class 2 Drugs with a high dose, low binding to plasma proteins, and a high free fraction (e.g., sulfonamides).

The Class II drug displaces the Class I drug from plasma proteins, increasing the free fraction of the Class I drug, which can lead to toxicity.

Summary:

Free Drug: Only the free (unbound) drug is active.
Class I Drugs: Low dose, high binding to proteins (most of the drug is bound).
Class II Drugs: High dose, low binding to proteins (most of the drug is free).
Displacement: Class II drugs can displace Class I drugs from proteins, increasing the free fraction of Class I drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the purpose of Phase I reactions in drug metabolism?

What happens during Phase II reactions?

Why is biotransformation important for drug elimination?

A

To convert lipophilic (fat-soluble) drugs into more polar (water-soluble) molecules, making them easier to excrete.

The drug is conjugated with a polar molecule (e.g., glucuronic acid, sulfuric acid) to further increase its water solubility and prepare it for excretion.

It converts fat-soluble drugs into water-soluble forms, allowing them to be excreted by the kidneys and preventing toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is an enzyme inducer, and how does it affect drug plasma levels?

What is an enzyme inhibitor, and how does it affect drug plasma levels?

A

An enzyme inducer increases the production or activity of liver enzymes, causing drugs to be broken down faster. This leads to decreased plasma levels and reduced drug effect.

What is an enzyme inhibitor, and how does it affect drug plasma levels?
Answer: An enzyme inhibitor blocks or reduces the activity of liver enzymes, causing drugs to be broken down slower. This leads to increased plasma levels and increased drug effect (or toxicity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Q: What is the elimination half-life (t½ elim) of a drug?

How does distribution half-life (t½ α) differ from terminal half-life (t½ β)?

A

The half-life (t½) of a drug is the time required for its plasma concentration to decrease by 50% through elimination, distribution, or metabolism. It is a critical pharmacokinetic parameter that determines:
How often a drug must be dosed.
How long it takes to reach steady state.
How long the drug remains in the body after stopping.

Time for plasma concentration to decrease by 50% due to metabolism/excretion. Determines dosing frequency (e.g., t½ = 6h → dose every 6h).

t½ α: Rapid initial drop due to drug leaving blood for tissues (e.g., fentanyl: 5 min).
t½ β: Slow final elimination (e.g., diazepam: 48h).

22
Q

How to remember clearance and what’s its unit

A

The easy way to remember it is to remember its unit and its
(mL/min)

23
Q

What is Steady-State?

A

point where the rate of drug administration equals the rate of elimination, resulting in a stable plasma concentration

24
Q

Time to Reach Steady-State

A

Rule: Steady-state is achieved in 4–5 half-lives of continuous infusion or regular dosing.

A drug with a half-life of 6 hours reaches steady-state in ~24–30 hours.

25
Loading Dose
Purpose: Rapidly achieve therapeutic plasma levels when immediate effect is needed.
26
Maintenance Dose
Purpose: Replace the drug eliminated since the last dose to maintain steady-state.
27
Influence of Infusion Rate
Faster Infusion: Reaches steady-state no sooner (still 4–5 half-lives) but produces higher peak levels (risk of toxicity).
28
How many half-lives are needed to reach steady-state during IV infusion? Why is a loading dose used? What happens to plasma drug levels after stopping an infusion?
4–5 half-lives (e.g., drug with t½ = 8h → steady-state in 32–40h). To rapidly achieve therapeutic plasma levels when immediate effect is needed (bypasses wait for steady-state). Levels drop to negligible (~3%) in 4–5 half-lives (e.g., t½ = 12h → drug clears in 48–60h).
29
Why is vancomycin dosed 2–3x/day but amiodarone once daily? Q: What happens if a drug with t½ = 4h is dosed once daily?
Vanco has a short t½ (~6h) and needs stable levels; amiodarone has a long t½ (58 days) and accumulates. A: Levels will drop below MEC most of the day → Treatment failure. Take-Home Rule Dosing frequency = Keep levels in the therapeutic range 24/7. Short t½ → Frequent doses | Long t½ → Fewer doses.
30
So what’s accumulation
Its increase in plasma level where the next does has been administrated before the full elimination of the last one And usually the amount of the drug in the body increase until it reaches a steady state Or accumulation may increase dramatically in case of renal frailer or liver failer.
31
PANS and SANS egenskapar
PANS • preganglionic fibers are long; • ganglions are located on the organs or nearby; • postganglionic fibers are short SANS • preganglionic fibers are short; • ganglions are located along the vertebral column; • postganglionic fibers are long
32
EXPlain ACH and nicotine receptors path want on pre and post gangalia on PANS and SANS
Preganglionic neurons (both PANS and SANS): They release acetylcholine (Ach), which acts on nicotinic receptors in ganglia (and in the adrenal medulla). Postganglionic neurons: • In the parasympathetic system (PANS): They release acetylcholine (Ach). • In the sympathetic system (SANS): They release norepinephrine (NA). Adrenal Medulla: Acts like a sympathetic ganglion by receiving acetylcholine and then releasing stress hormones (epinephrine/norepinephrine).
33
WHATS the combinination of ACH and what organelle is producing both parts and what enzyme make the ACH in the synapse and transfer it to the vesicles
Choline we get from the diet actyl coa is produced by the mitocondra so ACH Choline transfarase will make ACH from choline and acetyle COA
34
Tell me short the pathway of cholinergic neurons step by step
1. Ach synthesis (acetylcoenzyme A + choline) 1. 2. Ach storage (vesicles) 3. Ach release (synaptic cleft) 4. Ach binding to receptors (presynaptic and postsynaptic M +N) 5. Catabolism of Ach (by acetylcholinesterase) 6. Reuptake of Ach metabolites (back to cholinergic neuron)
35
SIGNALING MECHANISMS OF CHOLINERGIC RECEPTORS Muscarine
M2 will Stimulate Gi protine inhibitory that will inhibit AC will lead to decrease of cAMP and PKA Gi Beta unite will activate potassium channel opening and outflow of potassium and inhibit of ca influx. and will lead DECREASE of PPPPP and the inhibition of the muscle for example heart and Will decrease the heart rate. And this is increase of inhibitaionn of acetylcolinestarase as effect of a drug. M3 Stilmulatory will be Gq proteins that will. That will lead to phospholipids PCL lead to PIP2 will lead to activate DAG will activate PKC And IP3 will increase the Ca and Ca will increase the phophorylation and will stimulate the cell which mean more positive and contraction of the cell.
36
Classification of cholinomimetics and what do you block in indirect acting
Classification is direct acting and indirect acting In indirect you don’t block the proteins of Nictoinic nm or nn or musicol protein m2 m3 but here you block the ACH blocker which is actylcolinester enzyme
37
TOXICITY OF DIRECT- ACTING CHOLINOMIMETICS Muscarinic?
CNS: stimulation depression of respiratory center RAIN MA. body fluid. miosis, accommodation spasm nausea, vomiting, diarrhoea enuresis sweating→ “wet”, hypersalivation, bronchoconstriction, ↑bronchial secretion dou to stimulation of M2 ↓BP, bradycardia ATROPINE will be the drug antagonist to work as a blocker of Muscarine.
38
INDIRECT-ACTING CHOLINOMIMETICS. IRREVERSIBLE AChE INHIBITORS Muscarinic effects Nicotinic effects
These drugs prevent the breakdown of acetylcholine (ACh) by inhibiting acetylcholinesterase (AChE), but they do it permanently. echothiophate duration of action 2-7 days usage→ only glaucoma Parathion (pesticides) Soman, Sarin (neurotoxic gas) Muscarinic effects: bradycardia or tachycardia, hypotension, salivation, lacrimation, miosis, accommodative spasm, bronchoconstriction, intestinal cramps, urinary incontinence; Nicotinic effects: depolarizing neuromuscular blockade, muscle weakness; NOTE activation of Ach receptors in CNS: seizures, respiratory depression, coma, DEATH
39
INDIRECT-ACTING CHOLINOMIMETICS. REVERSIBLE AChE INHIBITORS
All M+N All down lipphikicity but physostigmine Endrophonium Neostigmine Physostigmine high lipphilicity M+N 30-2h decrease Glaucoma antimuscarinic drugs antidote for atropine Pyridostigmine
40
41
MANAGEMENT OF ORGANOPHOSPHATE POISONING
USE OF ATROPINE(Ach receptor antagonist)→ USE OF PRALIDOXIME (CHOLINESTERASE activator) but it can not activate ache in the CNS that’s why we need to administate this drug as soon as possible With in 2 hours
42
Atropine Source of MachR antagonist Egenskaper and what does it do the eye lacrimal secretion and so on Effect on the cardio vascular system
Atropa belladonna deadly nightshade Datura stramonium jimson weed Hyoscyamus niger devils breath Lipid soluble Good distribution in the CNS Half life 2-3 hours Long lasting effect >72h Relax iris sphincter called mydriasis Relax ciliary muscle cycloplegia Decrease musociliary clearance Mucosciliary clearance NEW drug IPRATROPIUM TIOTROPIUM less risk tachycardia OXYBUTYNIN new drug more selective to M3 Cardio low doses bradycardia high doses tachycardia Scopolamine is a better choice than atropine in the CNS
43
Tell me about atropine
44
Muscadine antagonists toxicity
Hot dry atthymia constipationn urinary retention blurred vision mad hallucination redness
45
Nicotine receptors antagonist direct drugs
Nicotine first stimulates the ganglia then block it Hexamethonium: The drug block both Nn in SANS and PANS used for wide response Trimethaphan
46
Indirect NICTONIC block agents
These drugs stop acetylcholine (ACh) from being made, stored, or released, preventing nerve signals from reaching organs. Hemicholinium transport block Vesamicol storage block in vesicals Botulinum toxin breaking protein need for the signals cleaves synptobrevins Clinical use blepharospasm spasticity Side effects Arrhythmia muscle weakness dropping eyelids
47
NEUROMUSCULAR JUNCTION – BLOCKING DRUGS (MYORELAXANTS). DEPOLARIZING group
Succinylcholine which block muscle movement composed of 2 ach molecules Ressistant to ache unlike ach In phase 1 its non reversible muscle twitching in phase 2 it can be reversed and neostigmine which is ache inhibitor Used for tracheal relaxation Adverse effect bradycardia arrhythmia increased potassium apnea short lasting 5-10 min
48
NEUROMUSCULAR JUNCTION– BLOCKING DRUGS (MYORELAXANTS) NONDEPOLARIZING GROUP:
They don’t depolarize the postnysapitc membrane but block presynaptic nicotinic receptors NAchR which prevent the release of ach wich will prevent the muscular contraction NEOSTIGMINE can be used to reverse the action Its long lasting 1-2h Adverse reaction bronchospasm hypotension tachycardia
49
Action of the eye depends on what receptors and what drugs
It depends on M3 receptor which will contract the muscle and will have smaller pupil miosis which is seen with cholinomimic drugs like pilocarpine and carbachol leads to IOP decrease and near vision Cholinblocker atropine cause pupil dialation increase IOP promote far vision